-
-
-
-
-
-
-
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
-
-
-
-
-
-
-
AC Immune Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
AC Immune Appoints Experienced Biotech and Investment Executive Dr. Alan Colowick to Board of Directors
-
-
-
-
-
-
-
AC Immune SA (ACIU), Piramal Imaging Present First Clinical data for tau PET-imaging Tracer at Alzheimer's Conference
-
1,155,028 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

